SCHEMBL24378526

SCHEMBL24378526

CCC(C)(C)CCC(C)(C)SC

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18739050 0.81
SCHEMBL20609970 0.78 TSHR (0.46) TSHRTDP1
SCHEMBL20017876 0.76
SCHEMBL13696821 0.74 TSHR (0.32) TSHRTDP1
SCHEMBL7967487 0.73
SCHEMBL290886 0.72
SCHEMBL7971234 0.69 TSHR (0.47) TSHRTDP1
SCHEMBL15587131 0.69
SCHEMBL13520564 0.69
SCHEMBL17607595 0.67 TSHR (0.35) TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022084738-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS Azura Ophthalmics Ltd. (IL) 2022-04-28 WO disclosed